256 Newsroom — Uganda's Digital News Infrastructure
Business

Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped - fiercebiotech.com

Published by FierceBiotech By James Waldron · 7 September 2026 at 15:39
Share
Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped - fiercebiotech.com
Image · FierceBiotech

What the report says

Novo Nordisk has given up on two more phase 3 trials of ziltivekimab, further eroding the prospects for a molecule that analysts had once tipped as a potential blockbuster. | Novo Nordisk has given up on two more phase 3 trials of ziltivekimab, further erodin…

Read the full report at FierceBiotech →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

Why Uganda wants private money to help transform farmingThe Observer 256 Newsroom Tension as Koboko, Yumbe dispute Araga boundary - monitor.co.ugDaily Monitor 256 Newsroom KCCA’s revenue bet: Help businesses survive, then tax their growth - Daily MonitorDaily Monitor 256 Newsroom Kenya gives foreign traders 90 days to comply - Daily MonitorDaily Monitor 256 Newsroom Uganda Targets 3,500 Tonnes of Coffee Exports to South Korea Under New Deal - ChimpReportsChimpReports 256 Newsroom URA Exposes Cigarette Smuggling Hideout Behind Welded Metal - ChimpReportsChimpReports